Glasgow alcoholic hepatitis score (GAHS)
Forrest E H, et al.
1
identified 241 patients with alcoholic hepatitis and recorded clinical and laboratory data on admission (day 1) and on days 6 through 9 with the goal of determining which variables were strongly correlated with outcome at 28 and 84 days after admission. At the completion of the study, the GAHS score on day 1 had an overall accuracy of 81% when predicting 28 day outcome, while the modified discriminant function had an overall accuracy of 49%. The GAHS was similarly effective using information at days 6 to 9 when predicting 84 day outcome.
Age (years)
:
<50
>/= 50
WBC
:
<15 (10
9
/L or 10
3
/μL)
15 or greater (10
9
/L or 10
3
/μL)
Urea
:
<5 (umol/L) or
<14
(mg/dL)
5 or greater (umol/L) or
14 or greater (
mg/dL)
PT ratio
:
<1.5
1.5 - 2.0
>2
Bilirubin
:
125 (μmol/L) or <7.3 (mg/dL)
125 - 250 (μmol/L) or 7.3 - 14.6 (mg/dL)
>250 (μmol/L) or >14.6 (mg/dL)
Background Info
Glasgow Alcoholic Hepatitis Score (GAHS)
:
Range: 5 to 12. There is a marked rise in mortality when the score is greater than or equal to 9.
Scoring
:
SI units
Score
Parameter
:
1
2
3
Age
<50
>/=50
-
WBC
<15
>/=15
Urea (mmol/L)
5
>/=5
PT ratio
<1.5
1.5-2
>2
Bilirubin (μmol/l)
<125
125-250
>250
Conventional units
Score
Parameter
:
1
2
3
Age
<50
>/=50
-
WBC 10
9
/L
<15
>/=15
Urea (mg/dL)
14
>/=14
PT ratio
<1.5
1.5-2
>2
Bilirubin (mg/dL)
<7.3
7.3-14.6
>14.6
Survival from alcoholic hepatitis with respect to individual Glasgow alcoholic hepatitis score (GAHS) values
1
.
Day 1 score
:
Less than 9
:
Day 28 survival (%): 87
Day 84 survival (%): 79
Greater than or equal to 9
:
Day 28 survival (%): 46
Day 84 survival (%): 40
------------------------
Day 6 to 9 score
:
Less than 9
:
Day 28 survival (%): 93
Day 84 survival (%): 86
Greater than or equal to 9
:
Day 28 survival (%): 47
Day 84 survival (%): 37
References
Forrest E H, Evans C D J, Stewart S. et al Analysis of factors related to mortality in alcoholic hepatitis and the derivation and validation of the Glasgow alcoholic hepatitis score. Gut 2005; 54; 1174-1179. [
PubMed
]